Embecta (EMBC) News
NASDAQ: EMBCHealth CareMedical/Dental InstrumentsUSD
6.02-0.17 (-2.75%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EMBC news summary
We found 2 recent headlines mentioning Embecta (EMBC): 2 in the past week and 2 in the past 30 days, most often from Business Insider, GlobeNewswire. For price context, EMBC is down 2.75% at $6.02. The most recent story, "embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results", was published by Business Insider on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Embecta headlines
- embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify" style="text-align:justify;">PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) --…Business Insider
- embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial ResultsPARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based…GlobeNewswire